Evidence map›Paper›PMID 27386475›Full record

ArticleEndoscopic ultrasound

Pathologic evaluation of a new endoscopic ultrasound needle designed to obtain core tissue samples: A pilot study.

Douglas G Adler, Benjamin Witt, Barbara Chadwick, Jason Wells, Linda Jo Taylor, Christopher Dimaio, Robert Schmidt

Abstract read
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Serous pancreatic neoplasia, data and review.World journal of gastroenterology · 2017
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Evaluation of the SharkCoreEndoscopic ultrasound
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Douglas G AdlerDepartment of Gastroenterology and Hepatology, University of Utah School of Medicine, Utah, USA.
Benjamin WittDepartment of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Barbara ChadwickDepartment of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Jason WellsDepartment of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Linda Jo TaylorDepartment of Gastroenterology and Hepatology, University of Utah School of Medicine, Utah, USA.
Christopher DimaioDepartment of Gastroenterology and Hepatology, Mount Sinai School of Medicine, New York, USA.
Robert SchmidtDepartment of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, Utah, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesStandard endoscopic ultrasound-fine-needle aspiration (EUS-FNA) needles are in widespread use. Meaningful differences between the available needles have been difficult to identify. Recently, a new EUS needle (Shark Core®, Covidien, Dublin, Leinster, Ireland), has been introduced in an attempt to improve diagnostic accuracy, tissue yield, and to potentially obtain a core tissue sample. We performed a pilot study prospectively to evaluate this new needle when compared to a standard EUS-FNA needle. MATERIALS AND

methodsAnalysis of the first 15 patients undergoing EUS-FNA with the Shark Core needle was performed and it was compared to EUS-FNA in 15 patients who underwent EUS-FNA with a standard needle.

resultsThe Shark Core needle required fewer needle passes to obtain diagnostic adequacy than the standard needle [(χ(2)(1) = 11.3, P < 0.001]. The Shark Core needle required 1.5 passes to reach adequacy, whereas the standard needle required three passes. For cases with cell blocks, the Shark Core needle produced diagnostic material in 85% of cases [95% confidence interval (CI): 54-98], whereas the standard needle produced diagnostic material in 38% of the cases (95% CI: 9-76). The Shark Core needle produced actual tissue cores 82% of the time (95% CI: 48-98) and the standard needle produced no tissue cores (95% CI: 0-71) (P = 0.03).

conclusionThis pilot study found that the Shark Core needle had a high rate of producing adequate cytologic material for the diagnosis of pancreatic and peri-pancreatic lesions sampled by EUS with fewer passes required to obtain a definitive diagnosis and with a high rate of tissue cores being obtained when compared to a standard FNA needle.

Indexed as

Core tissue samplesendoscopic ultrasound-fine-needle aspiration (EUS-FNA) needleEUS needleShark Core

Identifiers

PMID27386475
PMCPMC4918301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.